Comparing the Effects of Extracorporeal Shockwave Therapy and Splinting in the Treatment of Trigger Finger

Mahidol University0 sites24 target enrollmentJanuary 15, 2025

ConditionsTrigger Finger Shockwave Therapy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Trigger Finger
Sponsor: Mahidol University
Enrollment: 24
Primary Endpoint: 100-mm. horizontal VAS score
Status: Not yet recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The goal of this study is to compare the effects of extracorporeal shockwave therapy and splinting in the treatment of trigger finger.

Participants will:

Be randomized into two groups (shockwave group and splint group). Visit the clinic once a week for four weeks for therapy. Keep a diary of their symptoms, which will be reviewed at six weeks.

Registry

clinicaltrials.gov

Start Date

January 15, 2025

End Date

November 30, 2026

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Mahidol University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients age ≥ 18 years
•Grade I-III trigger finger patients (patients who has the presence of tenderness over the A1 pulley or painful locking or triggering as they fixed and extended the finger)
•Patients who consented to participation in the study

Exclusion Criteria

•Trigger thumb
•The patients who had received previous treatment (steroid injection, ESWT or surgical release)
•Patients with local infections, malignancies, severe coagulopathy and pregnancy

Outcomes

Primary Outcomes

100-mm. horizontal VAS score

Time Frame: at enrollment, fourth week, and sixth week after first intervention

The VAS or Visual Analog Scale is a scale that is used to evaluate the level of pain. It is represented by a horizontal line that is 100-mm. long. The score is determined by measuring the distance in mm. A higher score on this scale indicates greater pain intensity.

Secondary Outcomes

QuickDASH score(at enrollment, fourth week, and sixth week after first intervention)
Number of triggering(at enrollment, fourth week, and sixth week after first intervention)